On Friday, Shares of Dow Chemical Co (NYSE:DOW), subtract -0.92% and closed at $53.65 in the last trading session. The last trading range of the stock ranges between $52.88 and $54.07. The company’s Market capitalization is $59.61 Billion with the total Outstanding Shares of 1.12 billion. Chromatin Inc., an agriculture technology company, has signed an exclusive license agreement for unique sorghum genetic stocks developed by Agrigenetics Inc., an associate of Dow AgroSciences LLC, a wholly owned partner of The Dow Chemical Company (DOW).
Under the license agreement, Chromatin is deploying Dow AgroSciences’ sorghum technology to launch new, market-leading products in multiple key sorghum markets outside of the United States. “Chromatin has assembled and developed the industry’s leading product pipeline for sorghum,” said Daphne Preuss, CEO, Chromatin. “The materials licensed from Dow AgroSciences add critically important genetic diversity and allow Chromatin to bring higher yielding crops to our international customers.”
“At Dow AgroSciences, our innovative sorghum hybrids have wide adaptability around the world, and this agreement with Chromatin will assist meet the demand for new products with higher yield and stability in sorghum-growing geographies,” said Rolando Meninato, vice president, Seeds, Dow AgroSciences.
Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $40.26 and reached to max level of $57.10. The EPS of company is strolling at 6.20.
Shares of Coty Inc (NYSE:COTY), jumped 0.62 % and closed at $18.66 in the last trading session. The last trading range of the stock ranges between $18.28 and $19.29. The company’s Market capitalization is $14.01 Billion with the total Outstanding Shares of 75.10 million. Coty Inc. (COTY) recently declared an update on the P&G Specialty Beauty Business merger and financial results for the stand-alone Coty business, before the completion of the merger with P&G Specialty Beauty Business, for the first quarter of fiscal year 2017, ended September 30, 2016.
Coty Pre-merger – First Quarter Fiscal 2017 Summary
Net revenues of $1,080.2 million declined 3% as stated and declined 2% at constant currency
Stated operating income of $46.4 million reduced 43% from $81.7 million in the prior-year period
Adjusted operating income of $166.4 million reduced 14% from $192.6 million in the prior-year period
Stated net income reduced from $125.7 million in the prior-year period, while adjusted net income of $78.3 million reduced from $237.4 million in the prior-year period, with the prior-year period benefiting from a $113.3 million favorable tax settlement
Stated earnings per diluted share reduced from $0.34 in the prior-year period, while adjusted earnings per diluted share of $0.23 reduced from $0.64 in the prior-year period
Net cash (used in) offered by operating activities was $(15.0) million contrast to $116.7 million in the prior-year period
Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $18.28 and reached to max level of $31.60. The EPS of company is strolling at 0.08.